home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Unexpected Prion Link In Alzheimer's Disease

 
  March, 5 2009 19:33
your information resource in human molecular genetics
 
     

Amyloid-beta, a protein well known for its role in Alzheimer's disease, may yield its damaging effects on neurons by binding to the cellular prion protein (PrPC), a paper published in Nature suggests. This could make PrPC a potential target for Alzheimer's disease therapeutics.

Misfolded variants of PrPC have been implicated in prion diseases, such as bovine spongiform encephalopathy (BSE), but the normal endogenous version is found in many types of cell. In neurons, PrPC appears to act as a receptor for the amyloid-beta protein, Stephen Strittmatter and colleagues report. Moreover, they show that the deleterious effects of amyloid-beta on long-term potentiation in brain slices, an experimental model for learning and memory, are mediated by PrPC.

CONTACT

Stephen Strittmatter (Yale University School of Medicine, New Haven, CT, USA)
E-mail: stephen.strittmatter@yale.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.